Monogram Orthopaedics (NASDAQ:MGRM) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Monogram Orthopaedics (NASDAQ:MGRM) announced its earnings results on Wednesday. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Stock Performance

Shares of Monogram Orthopaedics stock opened at $2.31 on Friday. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90. The company has a market capitalization of $79.26 million, a P/E ratio of -4.91 and a beta of 1.66. The company has a fifty day moving average of $2.54 and a 200 day moving average of $2.50.

Analysts Set New Price Targets

MGRM has been the topic of several recent research reports. Roth Mkm began coverage on Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 price objective on the stock. Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a research note on Monday, December 9th.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.